NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW) between October 31, 2022 and March 26, 2024, both dates inclusive (the "Class Period"), of the important September 6, 2024 lead plaintiff deadline. SO WHAT: If you purchased SeaStar securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a cont ...

NEW YORK, Aug. 30, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW) between October 31, 2022 and March 26, 2024, both dates inclusive (the "Class Period"), of the important September 6, 2024 lead plaintiff deadline. SO WHAT: If you purchased SeaStar securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a conti ...

Core Viewpoint - SeaStar Medical Holding Corporation is facing a class action lawsuit due to alleged violations of federal securities laws, with investors encouraged to file claims for losses incurred during the specified class period [1][3]. Group 1: Legal Action and Investor Information - The Portnoy Law Firm is representing investors who purchased SeaStar securities between October 31, 2022, and March 26, 2024, with a deadline of September 6, 2024, to file a lead plaintiff motion [1]. - Investors can contact the law firm for a complimentary case evaluation and to discuss options for recovering losses [2]. Group 2: Allegations Against SeaStar - The complaint alleges that SeaStar and its executives made false or misleading statements regarding compliance controls for the HDE Application, leading to exaggerated regulatory prospects [3]. - Specific issues cited include inadequate financial controls, potential restatements of past financial statements, and misleading public statements about the company's business and financial prospects [3]. Group 3: Financial Restatement Announcement - On March 27, 2024, SeaStar announced it would restate financial statements for the fiscal year ending December 31, 2022, and interim periods through September 30, 2023, affecting the accounting of certain outstanding warrants and a prepaid forward purchase arrangement [4]. - The CEO indicated that the restatement would not significantly impact operations or cash position, but was related to non-cash accounting items [4]. Group 4: Market Reaction - Following the announcement of the restatement, SeaStar's stock price fell by $0.04 per share, or 5.41%, closing at $0.70 per share on March 27, 2024 [5].

NEW YORK, Aug. 29, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of SeaStar Medical Holding Corporation (NASDAQ: ICU). Shareholders who purchased shares of ICU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/seastar-medical-loss-submission-form/?id=98725&from=4 CLASS PERIOD: ...

Core Viewpoint - A class action securities lawsuit has been filed against SeaStar Medical Holding Corporation, alleging securities fraud that affected investors between October 31, 2022, and March 26, 2024 [1][2]. Summary by Sections Class Action Details - The lawsuit aims to recover losses for investors who were adversely affected by alleged securities fraud during the specified period [1]. - The complaint claims that SeaStar and/or Legacy SeaStar had inadequate compliance controls related to the Humanitarian Device Exemption (HDE) Application, leading to deficiencies that could hinder FDA approval [2]. - It is alleged that the company downplayed the severity of deficiencies in its financial controls and overstated efforts to remediate these issues [2]. - The lawsuit suggests that SeaStar failed to properly account for certain financial instruments, which may lead to restatements of previously issued financial statements [2]. - The company's public statements regarding its business and financial prospects were claimed to be materially false and misleading [2]. Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until September 6, 2024, to request appointment as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and there are no out-of-pocket costs for class members [3]. Firm Background - Levi & Korsinsky has a history of securing significant compensation for shareholders and has been recognized as a top securities litigation firm in the United States [4].

NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of SeaStar Medical Holding Corporation (NASDAQ: ICU). Shareholders who purchased shares of ICU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/seastar-medical-loss-submission-form/?id=98158&from=3 CLASS PERI ...

NEW YORK, Aug. 26, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW) between October 31, 2022 and March 26, 2024, both dates inclusive (the "Class Period"), of the important September 6, 2024 lead plaintiff deadline. So What: If you purchased SeaStar securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fe ...

NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW) between October 31, 2022 and March 26, 2024, both dates inclusive (the "Class Period"), of the important September 6, 2024 lead plaintiff deadline. SO WHAT: If you purchased SeaStar securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a conti ...

NEW YORK, Aug. 26, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of SeaStar Medical Holding Corporation (NASDAQ: ICU). Shareholders who purchased shares of ICU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/seastar-medical-loss-submission-form/?id=97701&from=4 CLASS PERIOD: ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In SeaStar To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 investing in SeaStar stock or options between October 31, 2022 and March 26, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YO ...